Krsnaa Diagnostics: Intimation of receipt of In - principle A pproval received from BSE Limited and National Stock Exchange of…

What happened

Krsnaa Diagnostics (KRSNAA) filed a disclosure with the exchanges on 8 October 2026 at 09:41 PM titled "Intimation of receipt of In - principle A pproval received from BSE Limited and National Stock Exchange of India Limited for issue of 16,21,000 convertible warrants on…".

Company snapshot

Krsnaa Diagnostics is a small-cap company, with a market value of about ₹1,793 crore.

The stock last traded at ₹552.7, against a 52-week range of ₹515–₹848.1 (34.8% below the high).

Before this filing the shares had moved −1.3% over the month and +1.4% over three months. Average daily turnover over the last 20 sessions was about ₹12.64 crore.

Promoters held 27.11% at the end of Q1 FY27. Foreign institutions owned 4.28% and domestic institutions 14.51%.

What history shows

BCEIE has no earlier approval filing from this company on record since May 2026.

Market-wide, 1,496 approval filings with an impact score of 50 or more saw an average next-day move of +0.2%, with 47% rising.

Past reactions describe what happened before; they are not a forecast.

In the news

Recent coverage elsewhere (links open the original publisher):

• Krsnaa Diagnostics Board Greenlights Sale of Diagnostic Equipment Worth Up to ₹120 Crore — Sahi, 28 Sept 2026
• Krsnaa Diagnostics Approves Sale of Diagnostic Equipment — Equitypandit, 29 Sept 2026
• Krsnaa Diagnostics Approves Sale Of Diagnostic Equipment For Up To 1.20 Billion Rupees — TradingView, 28 Sept 2026
• Vijaya Diagnostic Centre vs Krsnaa Diagnostics vs Suraksha Diagno — Univest, 25 Sept 2026
• Krsnaa Diagnostics board OKs sale of select diagnostic equipment for Rs 120 crore — Business Standard, 29 Sept 2026

Source

• Exchange filing (PDF)